Inhibikase Therapeutics, Inc.
NASDAQ:IKTBiotechnology
Healthcare
$1.30 +3.57%
+$0.06 today
- Market cap
- $182.35M
- Beta
- 0.97
- P/E (TTM)
- -3.4
- EPS (TTM)
- -$0.52
52W Low $1.33High $2.26
Volume 0.50M
Average 1.03M
Private 5-step workspace
Build a IKT investment thesis
Turn Inhibikase Therapeutics, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.
Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.
Continue the stock analysis
Jump to another research area for this company.